Novo-Dipam en es it fr

Novo-Dipam Brand names, Novo-Dipam Analogs

Novo-Dipam Brand Names Mixture

  • No information avaliable

Novo-Dipam Chemical_Formula


Novo-Dipam RX_link

Novo-Dipam fda sheet

Novo-Dipam msds (material safety sheet)

Novo-Dipam MSDS

Novo-Dipam Synthesis Reference

Reeder, Sternbach; U.S. Pat. 3,371,085 (1968)

Novo-Dipam Molecular Weight

284.74 g/mol

Novo-Dipam Melting Point


Novo-Dipam H2O Solubility

Slightly soluble (50 mg/L)

Novo-Dipam State


Novo-Dipam LogP


Novo-Dipam Dosage Forms

Tablets; Injectable solution

Novo-Dipam Indication

Used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome.

Novo-Dipam Pharmacology

Diazepam, a benzodiazepine, generates the same active metabolite as chlordiazepoxide and clorazepate. In animals, diazepam appears to act on parts of the limbic system, the thalamus and hypothalamus, and induces calming effects. Diazepam, unlike chlorpromazine and reserpine, has no demonstrable peripheral autonomic blocking action, nor does it produce extrapyramidal side effects; however, animals treated with diazepam do have a transient ataxia at higher doses. Diazepam was found to have transient cardiovascular depressor effects in dogs. Long-term experiments in rats revealed no disturbances of endocrine function. Injections into animals have produced localized irritation of tissue surrounding injection sites and some thickening of veins after intravenous use.

Novo-Dipam Absorption

Essentially complete, with a bioavailability of 93%.

Novo-Dipam side effects and Toxicity

Symptoms of overdose include somnolence, confusion, coma, and diminished reflexes. Respiration, pulse and blood pressure should be monitored.

Novo-Dipam Patient Information

Novo-Dipam Organisms Affected

Humans and other mammals